- Home
- FRAF vs TIL Comparison
FRAF vs TIL Comparison
Compare FRAF & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRAF
- TIL
- Stock Information
- Founded
- FRAF 1906
- TIL 2018
- Country
- FRAF United States
- TIL United States
- Employees
- FRAF N/A
- TIL N/A
- Industry
- FRAF Major Banks
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- FRAF Finance
- TIL Health Care
- Exchange
- FRAF Nasdaq
- TIL Nasdaq
- Market Cap
- FRAF 212.1M
- TIL 177.1M
- IPO Year
- FRAF N/A
- TIL 2021
- Fundamental
- Price
- FRAF $46.51
- TIL $19.87
- Analyst Decision
- FRAF
- TIL Strong Buy
- Analyst Count
- FRAF 0
- TIL 5
- Target Price
- FRAF N/A
- TIL $100.67
- AVG Volume (30 Days)
- FRAF 19.2K
- TIL 102.3K
- Earning Date
- FRAF 10-22-2025
- TIL 11-12-2025
- Dividend Yield
- FRAF 2.84%
- TIL N/A
- EPS Growth
- FRAF 5.82
- TIL N/A
- EPS
- FRAF 3.29
- TIL N/A
- Revenue
- FRAF $74,998,000.00
- TIL N/A
- Revenue This Year
- FRAF N/A
- TIL N/A
- Revenue Next Year
- FRAF N/A
- TIL N/A
- P/E Ratio
- FRAF $14.14
- TIL N/A
- Revenue Growth
- FRAF 8.15
- TIL N/A
- 52 Week Low
- FRAF $28.01
- TIL $10.80
- 52 Week High
- FRAF $49.42
- TIL $44.50
- Technical
- Relative Strength Index (RSI)
- FRAF 57.21
- TIL 48.92
- Support Level
- FRAF $43.47
- TIL $18.10
- Resistance Level
- FRAF $47.11
- TIL $20.32
- Average True Range (ATR)
- FRAF 1.04
- TIL 1.56
- MACD
- FRAF 0.15
- TIL 0.23
- Stochastic Oscillator
- FRAF 83.52
- TIL 46.31
About FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.